Per Artursson: If we are to aim for the top, we must tear down the glass ceiling
2020-11-09
Standing on the shoulders of giants, we will allegedly discover the way forward, so if one would ever cross our path, it would be a mistake not to try the view. Per Artursson, Professor of Dosage Form Design and Giant of Pharmaceutical Sciences, works at Uppsala Biomedical Centre, and the perspectives offered are undeniably interesting.

"No bastard who received the Nobel Prize has written anything worth reading afterwards," Ernest Hemingway is said to have muttered when receiving the news that the Swedish Academy had just awarded him the cultural world's most prestigious recognition. True or not, the prophecy fit well with Hemingway's own writing - and perhaps it is fortunate that so very few of us need to relate to some form of legend status. Nevertheless, some people receive the honor, most recently Per Artursson, Professor of Dosage Form Design at Uppsala University, who in the autumn of 2020 was appointed Giant of Pharmaceutical Sciences.
“I prefer to see it as an acknowledgement that I still deliver the goods. Above all I appreciate that so many have paid attention to our group's scientific contributions. For the special issue of the Journal of Pharmaceutical Sciences that highlights our work, the editors received more than fifty texts from around the world, which is far more than I could have imagined. At the same time, I have reached the point in my research career where I am now more pleased with the successes of former students than my own. Like when two of my former PhD Students were recently appointed professors. Or, as recently as yesterday, when one of our junior researchers received a national award.”
An afternoon in Per Artursson's company is an unpredictable journey. The joy of discovery that continues to put its mark on his research quickly puts color to the conversation as well: Education, internationalisation, the future of the academy, the menu is diverse and spiced with sharp analyzes. The desire to follow and develop his thoughts and ideas has likely followed from a young age. A biography of Per mentions daily discussions about politics and news in his boyhood home in Karlskoga. The same text also describes the adult professional's uninterrupted search for new scientific horizons.

“What I value most in the academic environment is the freedom to allow space for curiosity. Our group has had the privilege to try our fortunes along many unknown tracks, and if I for a moment look in the rearview mirror, I think as our main achievement that we have made an impact in every new direction. I sometimes get the question if I have ever regretted that I thereby also abandon my place among the world's most quoted in a specific discipline. In our performance-oriented profession, this objection is perfectly reasonable, but for me, the lure of new waters has always outweighed the protection of old hunting grounds.”
This, for the research world, somewhat unconventional attitude raises eyebrows also far beyond his own corridors. Already in the introductory lines of the above-mentioned special issue of the Journal of Pharmaceutical Sciences, it is reflected on the driving forces that has taken Per Artursson so incomparably far from the breakthrough of the early 90's with the groundbreaking results on Caco-2 cells - articles that still belong to the journal's most quoted ever. Three decades later, his career includes more than 200 publications and 30,000 citations in a variety of fields. “The truth is that the course changes are necessary for Per. To find new energy and not to get bored”, the reasoning ends. There is little to object to this. Except that the truth often contains several dimensions.
“The famous cancer researcher George Klein once said that a good research group takes care of itself, and that's where I feel we are. In our relatively small environment, every new recruitment must fit perfectly, and my starting point is to always hire people who are smarter than myself. We need motivated employees with the ability to raise their gaze, and over the years, many remarkable persons have begun their careers in our laboratory. I myself have learned the importance of challenging early in a permissive environment. To raise issues and let our younger colleagues make themselves heard in the conversation. Ideally, I also prefer that they go out into the world. USA, Europe, travel anywhere, as long as you gather impressions beyond our own little pond.”
As expected, Per did not hesitate when the opportunity to spend 1996 in The Woodlands knocked. Here, less than half an hour's drive north of Houston, Texas, the Artursson family arrived to meet a business climate characterized by financial strength and demands for success. With a focus on drugs for gene therapy, he laid the foundation for, upon returning to his home country, helping to establish the field in Sweden. He also brought with him perspectives that had yet not been found in Uppsala, but which today, a quarter of a century later, are beginning to gain a foothold in the Swedish model.
“My then six-year-old daughter participated in gymnastics in the USA. She had talents and made progress, but when it was time to compete, the coaches let the children they believed in the most for the day represent the team. The others assisted on the sideline, and then they all grew together in the joy of what they realized were common successes. At Uppsala University, there is the stated goal of placing high in international rankings. Absolutely, but if we are to aim for the top, we must dare to tear down glass ceilings and allow at least some form of elitism.”
The reasoning slides into leadership and the diametrically opposite views of the managerial role that prevails between academia and industry. Where larger corporations train their future leaders according to meticulously crafted plans, the universities appoint their managers with short notice and leave them with a few percent salary increase. "We need to become more professional. Plan our appointments in advance. Work with leadership training, parallel learning and knowledge transfer", states Per. The further the conversation goes, the clearer a person open with his opinions emerges. It is refreshing and uninterruptedly interesting. "I would never succeed as a politician," he admits, "but I am always careful to distinguish between issue and person." Again, it is difficult to have objections, especially since not even Per Artursson gets a free pass in his own visions.
“Stepping into the future presupposes that we senior researchers are prepared to let forward the next generation. This applies not least in teaching. Swedish universities today have the lowest number of teacher-led hours per student in Europe. Thus, we have to compete with quality, and to sharpen our educations further, we need to attract young, motivated teachers with the abilities to bring in new knowledge and influences. Of course, I realize that it is not in our human nature to step aside, but again, it is a matter of looking beyond your own ego. To accept that none of us is irreplaceable. That the important thing is not what we do, but why.”
Bit by bit, the image falls into place. The relatively complex portrait painted by colleagues - determined and competitive, but also spontaneous and generous - slowly get clear contours. Let’s give the word to Kathleen Giacomini, a researcher at the University of California, who states the Zen Buddhist wisdom "How you do something is how you do everything." After countless alpine vacations with the Artursson family, she has her opinion clear: “Per is an extraordinary downhill skier who is looking for the most difficult challenges. Deep fresh snow adds an extra dimension. Good skis are appreciated, but the most important equipment is and remains the brain. Only when the last lift is closed does he lean back on the sofa and tell warmly about his students, friends and children in Sweden”. In the piste as it is in the laboratory. But there is still one last piece missing before the puzzle is complete: How then will a newly appointed giant actually move forward in his field?
“In addition to our ongoing research and the platform for optimization and profiling of drugs that we run in collaboration with SciLifeLab, we have recently received three European grants that open many exciting doors for us. At the age of 64, my time is of course not unlimited, nor is it crucial that my ideas should be explored. What really matters is that pharmacy develops, and as long as our work delivers, we will continue our journey of discovery.”
FACTS: PER ARTURSSON
Title Professor of Dosage Form Design, Uppsala University.
Currently Appointed Giant of Pharmaceutical Sciences by the Journal of Pharmaceutical Sciences, the world's oldest pharmaceutical journal.
Lives In central Uppsala
Discusses Current Events, is an insatiable news consumer, everything from politics to culture goes down.
I remember meeting Torbjörn Fälldin, former prime minister of Sweden, who visited one of our graduate schools. I found him initiated, quick-thinking, analytical and far from the image that followed him.
Qualities I appreciate Openness and honesty, both professionally and privately
Finally, I want to recommend everyone To look up and see what is larger than yourself for the common good, but remember to distinguish between issue and person.
MORE INFORMATION
Visit Lab Artursson online URL
Also read A tribute to Professor Per Artursson (Journal of Pharmaceutical Sciences)
See full list Giants of Pharmaceutical Sciences
CONTACT
Per Artursson, Professor of Dosage Form Design
Department of Pharmacy, Uppsala University
Per.Artursson@farmaci.uu.se
text: Magnus Alsne, photo: Mikael Wallerstedt
Currently at SweDeliver
-
Meet our partners: Emplicure
2023-03-11
Emplicure AB is a small enterprise with big potential. Applying its patented bioceramic technology platform to innovations that respond to unmet needs, the company aims to improve the lives of both patients and consumers worldwide. We teamed up with Anna Franzén, Clinical & Regulatory BDO, to learn more about the importance of rolling up the sleeves whenever needed.
-
Researchers in focus: Ellen Bruntzell wants to increase our knowledge of peptide drugs
2023-03-11
“Being part of the SweDeliver network is a constant source of inspiration,” states Ellen Bruntzell, PhD student at Uppsala University, who in a research project connected to both the Faculty of Pharmacy and AstraZeneca contributes new knowledge about the mechanisms that cause aggregation of peptide-based medicines.
-
Record-breaking interest in SweDeliver summer internships
2023-03-09
With almost 70 high-quality applications from around the world, SweDeliver is facing the pleasant task of selecting the six master's students who during an intensive summer will experience drug delivery research at its very best.
-
New model to predict drug absorption reduces need for animal testing
2023-03-07
In a new thesis, Vicky Barmpatsalou, PhD student at SweDeliver, introduces new in vitro models to cost-effectively identify which drug candidates are best suited for oral delivery and absorption in the large intestine.
-
Numerous new publications by SweDeliver's junior researchers
2023-03-01
Throughout the winter, Vicky Barmpatsalou, Agnes Rodler, Staffan Berg and numerous other junior researchers at SweDeliver are publishing results that add valuable knowledge to the fields of drug delivery.
-
See panel discussion about the future of Swedish pharmaceutical manufacturing online
2023-02-27
How should the Swedish pharmaceutical industry secure access to future competence and attract manufacturing were questions in focus at SwedenBIO's conference 8 February with, among others, Christel Bergström, Uppsala University. Watch the discussion online now.
-
Apply now for a SweDeliver Summer internship 2023
2023-01-23
In summer 2023, SweDeliver offers highly motivated, late stage master students the opportunity to a 6 week research internship with one of our 16 industrial partners positioned in Sweden, Finland, Denmark or Belgium. Submit your application no later than 21 February.
-
Looking back at a successful 2022 for SweDeliver
2022-12-22
Looking out our windows in Uppsala at a sparkling winter wonderland, we watch another successful year for SweDeliver come to an end.
-
Meet our partners: Pharmetheus
2022-12-12
Pharmetheus AB provides expertise in pharmacometrics, an interdisciplinary discipline where complex data and model-based methods are applied to support drug development in all clinical phases and in all therapeutic areas. We asked Erik Sjögren, Senior Consultant, what added values that arise when the fields of drug delivery and pharmacometrics interact.
-
SweDeliver • Now also as Rollups
2022-12-12
You who are involved in SweDeliver can now use up to three rollups to profile our competence center's activities in connection with seminars, conferences and other gatherings. And you who spot our RollUps: Drop by and we will tell you more about our operations!
-
Sweden Inhalation Network unites Swedish expertise in pulmonary drug delivery
2022-12-12
Sweden Inhalation Network works to give a new generation of Swedish researchers access to leading expertise in pulmonary drug delivery. On Thursday 15 December, the network will present their operations and future initiatives at the SweDeliver and NextBioForm webinar series.
-
Nanoparticles pave the way for biological drugs in tablet form
2022-12-09
In a new study, researchers at Uppsala University show how specially designed nanoparticles pave the way for oral delivery of biological drugs. "That the particles are absorbed in large quantities in the intestinal cells may facilitate medication for patients that have to inject their biological drug," says Patrik Lundquist, researcher in Drug Delivery.
-
Martin Lord leaves his position at SweDeliver (but keeps his desk)
2022-12-08
Just a minute... Martin Lord, postdoc at SweDeliver, who after two years is leaving our national competence center for a permanent position at Uppsala University's research environment for biopharmaceuticals.
-
Researcher in focus: Julia Parlow aims to map biologic's path from injection to absorption
2022-12-08
“The project's close ties and relevance to the industry was what first drew my attention to SweDeliver,“ states Julia Parlow, PhD student at Uppsala University, who is currently developing a method to study the factors affecting the transport of biologics from subcutaneous injection site to absorption site.
-
Alexandra Teleki new member of the Particle Technology Forum (AIChE) executive committee
2022-12-05
Just a minute... Alexandra Teleki, Center co-Director of SweDeliver and researcher with a focus on pharmaceutical nanotechnology, that in January 2023 will join as the only non-American member of the Particle Technology Forum executive committee.
-
Vinnova praises SweDeliver in new evaluation
2022-12-01
SweDeliver continues to receive top marks for its successful research program and building of new networks and expertise for future drug delivery. This time from main financier Vinnova, emphasizing, among many things, the efficient collaboration that characterizes the competence center.
-
Researcher profile: Ann-Sofie Persson will explore the void between drug particles
2022-10-19
“My work in SweDeliver has given me a broader perspective on drug delivery,” states Ann-Sofie Persson, researcher in Pharmaceutical Technology who has remained involved in the center since the 2017 launch of predecessor Swedish Drug Delivery Forum.
-
Numerous new findings by SweDeliver's junior researchers
2022-10-14
During summer and autumn, Ires van der Zwaan, Marcus Wanselius, Ann-Christin Jacobsen and numerous other junior researchers at SweDeliver are publishing results that add valuable knowledge to the fields of drug delivery.
-
SweDeliver receives top marks in new evaluation
2022-10-14
SweDeliver fulfills the high expectations and is well equipped to reach its goals, states the Competence Center's Scientific Advisory Board in a new evaluation of the ongoing collaboration between Uppsala University and 16 pharmaceutical companies.
-
Uppsala University ranks 23rd in the world in Pharmacy & Pharmaceutical Sciences
2022-10-13
The 2022 Academic Ranking of World Universities is official: Uppsala University continues to climb in the field of Pharmacy & Pharmaceutical Sciences and now ranks 23rd in the world. "This is yet another acknowledgment that our determined work is fruitful," states Mathias Hallberg, Dean at the Faculty of Pharmacy.
-
Sara Mangsbo receives the BiotechBuilders Award
2022-10-13
“Receiving the BiotechBuilders Award 2022 provides valuable inspiration and hopefully contributes to consolidating Uppsala's and Biopharmaceutical’s places on the Swedish Life Science map,” states Sara Mangsbo, research director in immuno-oncology and WP-leader at SweDeliver..
-
New consortium to develop RNA-based treatment for Crohn's disease
2022-09-30
With over 5 million euros in funding from Horizon Europe, new knowledge consortium GENEGUT will develop an RNA-based therapy against inflammatory disease in the gastrointestinal tract. "It is inspiring to take on a challenge with such extensive medical needs," says Per Artursson, Professor of Dosage Form Design.
-
PhD thesis provides new knowledge about oral delivery of biological drugs
2022-09-28
Biological drugs have an increasingly important function in healthcare, but despite numerous years of research, physicians often lack effective methods to give them as tablets. In a current PhD thesis, Staffan Berg presents new knowledge about how permeation enhancers and correct release profile can increase the absorption of biological drugs in the blood when delivered orally.
-
Center Director Christel Bergström: From a very productive spring to an equally exciting autumn
2022-06-27
Spring semester has come to an end, and what a productive one we have had! Our research is resulting in numerous scientific articles. SweDeliver´s research program is in focus of reflective talks at both national and international level. And this June, our first PhD student successfully defended his doctoral thesis!
-
Faculty of Pharmacy at the top of international rankings
2022-06-21
Rankings of universities and individual researchers are gaining increasingly more attention. A high position can attract new students, leading researchers and important funding - and currently the most prestigious rankings offer very inspiring reading for everyone with connections to the Faculty of Pharmacy.
-
The Faculty of Pharmacy ready for ULLA Summer School 22
2022-06-21
In early July, Uppsala University’s Faculty of Pharmacy welcomes PhD students and researchers from all over Europe to the ULLA Summer School 22, a unique experience that will bring together the future leaders in international pharmacy.
-
In focus: Maryam Tofiq keeps all professional possibilities open
2022-06-21
“Being a SweDeliver junior researcher, you often interact with companies in different sizes, countries and focus areas. To me, this is providing many important opportunities to develop my skills in scientific communication and project management, says PhD student Maryam Tofiq.
-
Many new publications by SweDeliver's junior researchers
2022-06-21
During the spring and early summer, Staffan Berg, Vahid Forooqi Motlaq, Ann-Sofie Persson, Maryam Tofiq and numerous other junior researchers at SweDeliver are publishing results that add valuable knowledge to the fields of drug delivery.
-
SweDeliver and NextBioForm launch dates for autumn webinars
2022-06-20
SweDeliver and NextBioForm will continue their joint webinars throughout the autumn term of 2022. The dates are are now available to experience presentations from the centers' junior researchers, special guest lectures and meetings with industrial partners. Welcome online August 25 for the first webinar of the autumn.
-
Get ready for the 1st SweDeliver Summit
2022-06-20
SweDeliver invites to Summit 29–31 August 2022, the very first time that the entire Competence Center will meet IRL. The conference, taking place at Gällöfsta Conference – located less than 70 km south of Uppsala – will also be visited by the SweDeliver Scientific Advisory Board.
-
New Podcast: SweDeliver at the Speed Of Life
2022-06-20
Meet Center directors Christel Bergström, SweDeliver, and Cecilia Persson, AM4Life, in a special edition of STUNS podcast Speed of life, discussing the possibilities and challenges that come with coordinating world leading research and competence centers.
-
New thesis with focus on microgels as tools for drug delivery
2022-05-24
Tuesday 14 June, Yassir Al-Tikriti, researcher at SweDeliver and Uppsala University’s Department of Medicinal Chemistry, presented his thesis Microgels as drug delivery vehicles: Loading and release of amphiphilic drugs.
-
Double success for SweDeliver on the IVA 100 list
2022-05-11
SweDeliver and ADAC, a new technology with potential to open new doors in cancer treatment developed by Sara Mangsbo, Senior lecturer and egaged in SweDeliver, takes place on the IVA 100 list, this year focusing on Technology in the service of mankind.
-
Ilse Dubbelboer sees her scientific future in Uppsala
2022-04-20
With the launch of a new model to calculate optimised bioavailability of subcutaneously administered biological drugs, Ilse Dubbelboer, researcher at SweDeliver, hopes to pave the way for better treatments with injected pharmaceuticals – preferably with Uppsala as her home.
-
SweDeliver Retreat 2022 receiving top marks
2022-04-20
“It was both fun and educational to finally meet everyone and get an overall picture of the ongoing projects," says Rosita Kneiszl Pettersson, PhD student in SweDeliver and one of 30 participants at the SweDeliver Retreat 2022.
-
Several new publications from SweDeliver's junior researchers
2022-04-20
SweDeliver continues to conduct high quality research. In the spring of 2022, Vicky Barmpatsalou, Ilse Dubbelboer, Agnes Rodler and Yassir Al-Tikriti are publishing articles that add important knowledge to the field of parenteral and oral drug delivery.
-
Great demand for expertise in ADME profiling
2022-04-19
With high-quality ADME-profiling, UDOPP provides Sweden's pharmaceutical researchers the data to decide whether their molecules are ready for the next level. The platform has already paved the way for numerous high impact publications and new companies, but now the team identify future challenges.
-
Meet our partners: Ultimovacs
2022-04-12
Ultimovacs is a Norwegian pharmaceutical company with focus on the development of new immunotherapies for cancer. The company portfolio includes UV1 - a potential peptide-based vaccine, as well as the patent-protected TET platform.
-
Meet the students that are up for the best summer job of 2022
2022-04-07
“It is fantastic that Uppsala University provides its students, not least us from other countries, this extraordinary opportunity," states Jessica Mahajan, Master's student in Drug Discovery and Development and one of six students selected to do a summer internship at SweDeliver's industrial partners.
-
SweDeliver inviting students to do degree projects at industrial partners
2022-04-04
Starting in the spring of 2022, SweDeliver will offer students the opportunity to do degree projects at one of the center's industrial partners. "This is a good way to further strengthen the ties between academia and industry," states Jonas Fagerberg, Head of Pharma R&D at Disruptive Pharma.
-
Uppsala-based Enphasys up for new EU initiative Women TechEU
2022-03-31
Just a minute… Christel Bergström, Center Director at SweDeliver and co-founder of Enphasys AB, one of 50 European companies that receive 75,000 euros in the European Union's new initiative Women TechEU, drawing attention to startups with women at top.
-
SweDeliver and NextBioForm launch dates for spring webinars
2022-02-02
SweDeliver and NextBioForm will continue their joint webinar series through spring 2022. The program offers a wide range of topics and presentations from our junior researchers. Welcome online for the premiere 3 February.
-
Betty Lomstein Pedersen is new Co-Lead in the Oral Drug Delivery Work package
2022-02-02
Just a minute… Betty Lomstein Pedersen, Lead scientist at Ferring Pharmaceuticals and new Co-Lead in SweDeliver's Oral Drug Delivery Work package, who sees a center with fundamental research of both high quality and industrial relevance.
-
New results on stabilising the boundary between collapsed and swollen phases in microgels
2022-02-01
In a new article published in Gels, Yassir Al-Tikriti, PhD student at SweDeliver, presents results supporting the hypothesis that the boundary between collapsed and swollen phases in the same microgel is stabilised by thermodynamic factors.
-
Now hiring: Two PhD Students in Molecular Pharmaceutics
2022-01-31
SweDeliver is now recruiting two PhD Students in Molecular Pharmaceutics. Welcome to submit your application no later than 18 February 2022.
-
Do your degree project at SweDeliver's industrial partners
2022-01-04
SweDeliver now offers students the opportunity to do a degree project consisting of 30 or 45 credits at one of our industry partners. Welcome to submit your application or contact us for more information.
-
Pharmetheus increases SweDeliver commitment with new project
2022-01-03
SweDeliver industrial partner Pharmetheus has been granted financing by Vinnova for the project Subcutaneous drug delivery: PBPK-QSP model for absorption and anti-drug antibody response. An initiative that will further invigorate the company's commitment in SweDeliver.
-
Center Director Christel Bergström After a very productive 2022 SweDeliver continues to grow
2021-12-17
Two years in, SweDeliver can look back at a very productive 2022. Several of the PhD students have had their half time evaluations, all of them with very positive feed-back on the research performed. A large number of scientific articles have been produced and an open webinar series has been given, where SweDeliver´s young researchers and industrial partners presented and discussed the research frontier.
-
Apply now for a summer work in a research intensive environment
2021-12-17
In summer 2022, SweDeliver offers highly motivated, late stage master students the opportunity to a 6 week research internship with one of our 16 industrial partners positioned in Sweden, Finland, Denmark or Belgium. Submit your application no later than 28 February.
-
Self-learning machines will show the way to better drug therapies
2021-12-16
“AI research can quite possibly already have the tools we need,” says Per Larsson, researcher at Uppsala University that, with the help of machine learning, aim to develop methods to calculate the solubility and absorption of oral peptide drugs into blood circulation.
-
Johan Palm is new Co-Lead in the Oral Drug Delivery Work package
2021-12-16
Just a minute… Johan Palm, Associate Principal Scientist at AstraZeneca and new Co-Lead in SweDeliver's Oral Drug Delivery Work package, who identifies both skilled junior researchers and opportunities for increased collaboration.
-
Irès van der Zwaan paves the way for new inhaled drugs
2021-12-15
“The diversity that characterizes SweDeliver is inspiring to be part of,” states Irès van der Zwaan, PhD student at Uppsala University’s Faculty of Pharmacy aiming to develop a new system for controlled release of drugs in the lung.
-
New SweDeliver study gains international recognition
2021-12-14
An article published by Rosita Kneiszl Pettersson et al. at SweDeliver showing that permeation enhancers for oral absorption can induce membrane leakiness in a concentration dependent manner, has been selected as ACS Editors' Choice, a program highlighting a limited number of articles from more than 60 peer-reviewed journals.
-
SweDeliver announces recruitment of summer interns 2022
2021-12-13
SweDeliver is preparing to hire summer interns 2022. “Both students and companies that participated last summer were extremely positive, so it is an easy decision for us to develop this concept further, says Center Director Christel Bergström.
-
Several new publications by SweDeliver's junior researchers
2021-12-10
SweDeliver's PhD students and postdocs continue to conduct studies of very high quality. In the autumn of 2021, Vicky Barmpatsalou, Staffan Berg, Vahid Forooqi Motlaq and Irès van der Zwaan have all presented interesting publications.
-
27 January 2022 • Pharmaceutical Profiling in Drug Discovery and Development
2021-12-10
Welcome online for the 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development with themes: New drug modalities & Data driven life sciences. No admission fee. Registration is open.
-
Boundless commitment • Science outreach in practice
2021-12-09
Half a century after Science outreach was written into the Higher Education Act, the researchers at the Faculty of Pharmacy are frequently engaged as experts in the media. They contribute knowledge in government inquiries and navigate international collaborations. But how can a young researcher prepare for a career in the limelight?
-
Christel Bergström receives SEK 2.4 million grant to develop virtual intestines
2021-11-23
Christel Bergström, Professor at the Faculty of Pharmacy and Center Director at SweDeliver, receives SEK 2.4 million from the Swedish Research Council for the development of virtual intestinal environments that can provide key resources in studies of how drugs will behave in the intestine.
-
SweDeliver's summer internships valuable for all parties
2021-10-19
”Hiring a SweDeliver intern was a win-win that definitely added value,” states Mattias Springfelter, Head of Pharmaceutical Development at Orexo AB, one of six companies that in the summer of 2021 welcomed a student to experience drug delivery science at its very best.
-
Mentoring program with restrictions and new dimensions
2021-10-19
In October, PhD students and mentors gathered in Uppsala to wrap up the first round of SweDeliver's new mentoring program. Although the pandemic limited most possibilities of interaction, no signs of digital fatigue were to be seen.
-
Meet our partners: Clinical Trial Consultants
2021-10-18
Clinical Trial Consultants AB (CTC) is a Swedish full-service and contract research organisation with clinical conduct in focus. The company facilitates clinical and translational research by providing cost-effective advice, planning, clinical execution, analysis and reports of early clinical trials.
-
Bertil Abrahamsson is new chair of SweDeliver
2021-10-18
Just a minute… Bertil Abrahamsson, Senior Principal Scientist at AstraZeneca and new chair of the SweDeliver Center Board, who recognizes a well-oiled machinery when he sees one.
-
SciLifeLab leads new national investment in oligonucleotides
2021-10-18
OligoNova is a new technology platform for the development of oligonucleotide therapeutics, by many seen as a cornerstone in tomorrow's treatments. "This initiative can be of great importance for both Sweden and future drug development," states Kristian Sandberg, head of SciLifeLab's Drug Discovery and Development Platform.
-
Researcher profile: Mats Karlsson creates his own scientific arena
2021-10-18
Pioneer and portal figure are two attributes often used too lightly. Sometimes it's all the more difficult to avoid them. In 2001, Mats Karlsson was named the world's first Professor of Pharmacometrics. Twenty years and 400 scientific publications later, he has no plans to reduce his efficiency.
-
New knowledge about the gastrointestinal mucus important to humans and animals
2021-10-18
With her research on gastrointestinal mucus, Vicky Barmpatsalou, PhD student at SweDeliver, is breaking new ground towards more efficient development of drugs for oral medication and fewer animal experiments in pharmaceutical research.
-
Uppsala University invests in lifelong learning for pharmacists
2021-10-14
With four new courses in drug development, the Faculty of Pharmacy takes an important initiative in Sweden's ongoing investment in lifelong learning. "Our field is constantly moving forward and already ten years after graduation, professional pharmacists should update their skills," says Senior lecturer Per Larsson.
-
New research to improve use of amphiphilic drug molecules
2021-05-18
By exploring the aggregation properties of different amphiphilic molecules in microgels, Yassir Al-Tikriti, PhD student at SweDeliver, aims to provide tools and knowledge of importance for future cancer therapies and antidepressants.
-
“The perfect challenge” • Meet this summer's SweDeliver interns
2021-05-17
“This is a unique opportunity for me”, states Anton Norberg, one of the six highly motivated master students selected by SweDeliver for a summer internship and the opportunity to experience drug delivery science at its very best.
-
Meet our partners: Janssen Pharmaceutica
2021-05-17
SweDeliver proudly welcomes Janssen Pharmaceutica (BE) as a full industry partner of our competence center. Being a company with core expertise in our research area, Janssen Pharmaceutica, will undoubtedly be a strong and dedicated partner of SweDeliver.
-
Samar Omer selected for summer internship at Orexo: “I anticipate to be part of the SweDeliver network”
2021-05-11
Selected by National Competence Center SweDeliver for a six week internship at Orexo AB, Samar Omer, Master student in in Drug Discovery and Development, aim to sharpen her already impressive curriculum vitae.
-
Stanko Skrtic: "SweDeliver gives reason for high expectations"
2021-05-10
Just a minute ... Stanko Skrtic, new chair of SweDeliver, whose first impressions of the national competence center best sums up: great capacity, genuine job satisfaction and high expectations.
-
“This is a perfect challenge” • Meet SweDeliver intern Sjoerd Koopman
2021-05-10
From Leiden via Nanjing to Uppsala and SweDeliver. For Sjoerd Koopman, master student in biomedicine, this summer will provide the opportunity to contribute to Clinical Trial Consultants work for a healthier world.
-
Pharmacystudent Anton Norberg: “SweDeliver’s is providing me a unique opportunity”
2021-05-10
Just a minute… Anton Norberg, student at Uppsala University's master of science programme in pharmacy and one of six very promising students selected by SweDeliver for a six-week summer internship at one of the centre's industrial partners.
-
Meet this summer's SweDeliver interns: Sara Hiidenhovi, University of Jyväskylä
2021-05-07
Meet the 3rd of six highly promising master students selected for research internships at SweDeliver's industrial partners: Sara Hiidenhovi, the Master programme in chemistry at the University of Jyväskylä, who will do her internship at Orion Pharma.
-
Meet this summer's SweDeliver interns: Yasmine Sundelin Tjärnström, Uppsala University
2021-05-07
Get ready to meet the 2nd of six master students selected by SweDeliver for research internships with our industry partners: Yasmine Sundelin Tjärnström, studying the master programme in Chemical Engineering, ready to spend the summer at Pharmetheus.
-
Meet this summer's SweDeliver interns: Shengtao Yu, Uppsala University
2021-05-07
SweDeliver are proud to present the six master students selected for research internships with our industrial partners. For these highly motivated students it will be a summer of drug delivery science at its very best in state-of-the art environments. Meet Shengtao Yu, ready to team up with Ultimovacs.
-
Now hiring: Researcher in molecular pharmaceutics
2021-04-07
SweDeliver is recruiting a researcher in molecular pharmaceutics for the project Structural characterization of formulated macromolecular drugs with lipids in response to dilution, digestion and permeation. Submit your application no later than 16 April 2021.
-
Apply now for a summer work in a research intensive environment
2021-02-12
This summer, SweDeliver offers highly motivated, late stage master students the opportunity to a 6 week research internship with one of our 15 industrial partners positioned in Sweden, Finland and Denmark. Submit your application today!
-
Stanko Skrtic new chair of the SweDeliver Center Board
2021-02-03
SweDeliver welcomes Stanko Skrtic, Medical Science Director at AstraZeneca R&D, as the new chair of our Center Board.
-
New seminar series puts focus on Swedish drug development
2021-02-03
This spring semester, SweDeliver and NextBioForm invite to online lunch seminars. Welcome to take part in current research with a focus on industrial challenges in drug delivery and the development of biologically based drugs.
-
Apply for the best summer job of 2021 at SweDeliver
2021-02-03
In the summer of 2021, SweDeliver will give five students the opportunity to conduct research on site at one of our industrial partners. Each project will extend over six weeks and constitute a platform for future recruitment of advanced students and PhD students to our competence center.
-
Meet our partners: Affibody AB
2021-02-03
Affibody is a clinical stage Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
-
New research to enable increased drug doses to the lung
2021-02-02
By exploring the physical stability of particles during pulmonary drug delivery, Sohan Sarangi, PhD student at SweDeliver, is providing important knowledge about optimising the amount of drug delivered to the lungs.
-
ERC Grant for research on new method to diagnose and treat inflammatory bowel disease
2021-01-26
Just a minute… Alexandra Teleki, Center co-Director at SweDeliver and researcher in drug development, who receives 2 million euros from the European Research Council to develop a new method to diagnose and treat inflammatory bowel disease in children.
-
Testa Center takes Swedish life science to new heights
2021-01-26
Researchers within life sciences at Uppsala University and SweDeliver have access to Testa Center's high-quality laboratory environments. Here they will meet the infrastructure and expertise needed to take innovations to the next level.
-
New methods to predict release and absorption of orally administered drugs
2021-01-04
Friday 15 January at 09.15 Caroline Alvebratt, PhD student at the Department of Pharmacy, will defend her dissertation with focus on new methods to predict the release and absorption of orally administered drugs. Welcome to participate online via Zoom.
-
Per Artursson: If we are to aim for the top, we must tear down the glass ceiling
2020-11-09
Standing on the shoulders of giants, we will allegedly discover the way forward, so if one would ever cross our path, it would be a mistake not to try the view. Per Artursson, Professor of Dosage Form Design and Giant of Pharmaceutical Sciences, works at Uppsala Biomedical Centre, and the perspectives offered are undeniably interesting.
-
The SweDeliver Scientific Advisory Board identifies great potential
2020-11-06
“Our Scientific Advisory Board expressed that SweDeliver is moving in the right trajectory, providing a unique ecosystem with great potential to exceed the needs of all stakeholders,” states Center Director Christel Bergström.
-
Meet Orion Pharma – New partner in the SweDeliver network
2020-11-05
SweDeliver is honoured to welcome Orion Pharma to our partnership. Orion Pharma, founded in 1917 by Finnish pharmacists, is currently one of the Nordic region's leading pharmaceutical corporations with operations worldwide.
-
SweDeliver's junior researchers prepare their next career step
2020-11-05
With a focus on lifelong learning, SweDeliver's young researchers participate in a selection of activities within the Work package Training and Career Development. First on the schedule is a series of digital lunch seminars and a Mentoring program in collaboration with the center's industrial partners.
-
New study aim to provide safer oral administration of macromolecular drugs
2020-10-27
"Our project is developing in a very positive direction," says Staffan Berg, PhD Student at SweDeliver that, with base at both AstraZeneca R&D and Uppsala's Faculty of Pharmacy, hopes to add new knowledge to one of pharmaceutical research's oldest challenges.
-
The Pulmonary Drug Delivery Work Package – An ecosystem for research and competence development
2020-10-05
“SweDeliver has already extended the visibility and appeal of the Faculty of Pharmacy far beyond Sweden's borders. This enhances our ability to recruit top-of-the-line PhD students and postdocs.”, states Göran Frenning, Professor of Pharmaceutical Physics.
-
Oral Drug Delivery work package – A gold mine for junior researchers
2020-09-21
“Here, PhD Students and postdocs interact with leading research groups, aspiring start-ups and established companies. It is a dynamic environment that will ensure continued growth in the already dynamic Swedish life science sector.”
-
Parenteral drug delivery work package – Home to a diversity of high-quality research
2020-09-14
“This has become a melting pot for interdisciplinary talks, innovative thoughts and a shared desire to accelerate the process from idea to market-ready product. Here, novel methods are developed and inspired initiatives are shaped.”
-
SweDeliver is shaping the future of drug delivery
2020-09-09
This summer, SweDeliver – Sweden's first national competence center in drug delivery – was inaugurated. With the hub at Uppsala University's Faculty of Pharmacy, academia and industry will cooperate to push the boundaries for the development of new pharmaceuticals.